Advance in breakthrough cancer treatment eliminates serious side effects
An advance in the breakthrough cancer treatment known as CAR T-cell therapy appears to eliminate its severe side effects, making the treatment safer and potentially available in outpatient settings, a new USC study shows.
"This...
Can Anti-Aging Research Keep Us Healthy in the Long Run?
Searching for the fountain of eternal youth has been the dream of humanity for millennia. While this is still in the realms of science fiction, anti-aging companies are hoping to tackle aging-related diseases by...
The Biotechnology Patent Landscape – BioSpace
Mark Van Scyoc / Shutterstock.com
Most of the luxuries that we enjoy are the result of patented developments, especially in the field of biotechnology. Every time we take a medication, enjoy a food or beverage,...
Sabancı University opens biotechnology research unit – Turkey – Hurriyet Daily News
ISTANBUL
Istanbul has a new biotechnology research and development laboratory as a result of a partnership which includes Sabancı University Nanotechnology Research and Application Center (SUNUM)
“The studies to be carried out here will contribute to...
European Biotechnology in 2019 and Beyond: What’s Hot and What’s Not? – Labiotech.eu
We spend a lot of time focusing on specific developments in biotechnology, but sometimes it’s good to take a step back and look at the bigger picture. With this in mind, I asked three...
Biotechnology Industry Wants to Diversify Leadership – IndustryWeek
Understanding that diversity is good for the bottom line, The Biotechnology Innovation Organization (BIO) announced on April 16 that it’s taking action on trying to increase gender, racial, ethnic and LGBTQ representation on biotech...
This Biotech Turns Paper Waste into Biogas Using Enzymes
In sunny Turkey, the company Episome Biotech is developing a fermentation technique that digests paper waste and turns it into useful products such as biogas, biofuel, and fertilizer.
Mission: To transform paper waste from garbage...
Roche Extends Offer for Spark Therapeutics a Second Time, as Shareholders Balk at Tender...
Roche said today it will extend for a second time its tender offer for shares of Spark Therapeutics, the gene therapy developer it wants to acquire for $4.8 billion, as the pharma giant falls...
